Rialto Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Rialto Wealth Management's REGN Position: Q2 2026 in Review
Rialto Wealth Management reduced its Regeneron Pharmaceuticals (REGN) stake by 29% in Q2 2026, selling an estimated $1.36K and leaving 5 shares worth $3.12K. The position accounts for ﹤0.01% of the portfolio, ranked #947.
Rialto Wealth Management first reported a position in REGN in Q1 2025 and has held it in 5 quarters since. The position peaked at $5.41K in Q1 2026. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Rialto Wealth Management held 5 shares of Regeneron Pharmaceuticals worth $3.12K as of Q2 2026.
- Rialto Wealth Management sold 2 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $1.36K.
- Regeneron Pharmaceuticals made up ﹤0.01% of Rialto Wealth Management's portfolio in Q2 2026, its #947 holding.
- Rialto Wealth Management first reported a position in Regeneron Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
- Rialto Wealth Management's Regeneron Pharmaceuticals position peaked at $5.41K in Q1 2026.
- 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Rialto Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.